Related Experiment Videos
Non-viral peptide-based approaches to gene delivery
1Department of Pharmaceutics and Pharmaceutical Chemistry, Center for Controlled Chemical Delivery, University of Utah, Salt Lake City 84112-9452, USA. rmahato@hotmail.com
Journal of Drug Targeting
|February 22, 2000
Summary
Synthetic peptides offer a promising solution for non-viral gene therapy by improving DNA stability, cellular delivery, and nuclear transport of plasmids. This review explores peptide-based strategies to overcome key limitations in gene transfer for effective therapy.
Area of Science:
- Biotechnology
- Gene Therapy
- Nanomedicine
Background:
- Effective non-viral gene therapy requires precise control over plasmid DNA (deoxyribonucleic acid) stability, cellular uptake, intracellular trafficking, and nuclear retention.
- Current limitations include inefficient endosomal escape, susceptibility to cytosolic nucleases, and inadequate cytoplasmic transport and nuclear entry of plasmids.
Purpose of the Study:
- To review the theoretical and experimental aspects of DNA compaction for gene delivery.
- To explore methods for stabilizing compacted DNA under physiological conditions.
- To assess techniques for characterizing compacted DNA and review peptide-based strategies for efficient gene transfer.
Main Methods:
- Exploration of DNA compaction principles and stabilization techniques.
- Assessment of characterization methods for compacted DNA.
- Review of synthetic peptide-based systems for gene delivery.
Main Results:
- Synthetic peptides can be engineered for DNA compaction, serum stability, cell targeting, endosomolysis, and enhanced cytoplasmic and nuclear transport.
- Hydrophilic polymers like polyethylene glycol can improve the stability of compacted DNA in physiological environments.
Conclusions:
- Peptide-based gene delivery systems show significant potential to overcome major hurdles in non-viral gene therapy.
- Further research into these systems could lead to more effective and safer gene therapeutic applications.